Hospital Acquired Infections Completed Phase 3 Trials for Linezolid (DB00601)

Also known as: Hospital-Acquired Infection / Infections, Nosocomial / Nosocomial Infections / Nosocomial Infection / Hospital Acquired Infection / Hospital-acquired Infections / Infections, Hospital / Hospitalisation-associated infection / Hospitalization-associated infection / Cross Infection / Cross infection (disorder) / Healthcare associated infectious disease (disorder)

IndicationStatusPhase
DBCOND0044758 (Hospital Acquired Infections)Completed3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00150332Linezolid for the Treatment of Infections Caused by Methicillin Resistant Staphylococcus Aureus in JapanTreatment